Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
$ 26.71 -1.28%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Rigel Pharmaceuticals EV/EBITDA Ratio 2011-2024 | RIGL

Annual EV/EBITDA Ratio Rigel Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-28.4 -21.4 -5.54 -3.77 -5.88 -2.84 -3.97 -1.87 -2.98 -4.6 -7.06

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.87 -28.4 -8.03